Tumor-Targeting Nanodelivery Enhances the Anticancer Activity of a Novel Quinazolinone Analogue

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-07-0548
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Nanodelivery of Parthenolide Using Functionalized Nanographene Enhances Its Anticancer Activity

RSC Advances
ChemistryChemical Engineering
2015English

E1A Specifically Enhances Sensitivity to Topoisomerase II Targeting Anticancer Drug by Up-Regulating the Promoter Activity

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2005English

A Novel Oncolytic Adenovirus Targeting to Telomerase Activity in Tumor Cells With Potent

Oncogene
Cancer ResearchGeneticsMolecular Biology
2004English

A Tumor-Penetrating Peptide Enhances Circulation-Independent Targeting of Peritoneal Carcinomatosis

Journal of Controlled Release
Pharmaceutical Science
2015English

A Tumor-Targeting P53 Nanodelivery System Limits Chemoresistance to Temozolomide Prolonging Survival in a Mouse Model of Glioblastoma Multiforme

Nanomedicine: Nanotechnology, Biology, and Medicine
Materials ScienceMolecular MedicineNanosciencePharmaceutical ScienceMedicineBioengineeringNanotechnologyBiomedical Engineering
2015English

Cotreatment With a Novel Phosphoinositide Analogue Inhibitor and Carmustine Enhances Chemotherapeutic Efficacy by Attenuating AKT Activity in Gliomas

Cancer
Cancer ResearchOncology
2006English

Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-Crystal Structure

English

Bombesin Analogue-Mediated Delivery Preferentially Enhances the Cytotoxicity of a Mitochondria-Disrupting Peptide in Tumor Cells

PLoS ONE
Multidisciplinary
2013English

Anticancer Activity of Streptochlorin, a Novel Antineoplastic Agent, in Cholangiocarcinoma

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy